flestolol has been researched along with isoproterenol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, G; Grohs, JG; Raberger, G | 1 |
| Gorczynski, RJ; Hwang, TF; Murthy, VS; Rosen, LB | 1 |
| Liu, GD; Yue, WL | 1 |
| Achari, R; Bell, V; Drissel, D; Hulse, JD; Laddu, A; Matier, WL; Turlapaty, P | 1 |
| Liem, LB; Peterson, J; Swerdlow, CD | 1 |
| Achari, R; Bell, V; Burge, J; Hulse, J; Laddu, A; Mosberg, H; Turlapaty, P | 1 |
6 other study(ies) available for flestolol and isoproterenol
| Article | Year |
|---|---|
Effects of flestolol, an ultra-short acting beta-adrenoceptor antagonist, on hemodynamic changes produced by treadmill exercise or isoprenaline stimulation in conscious dogs.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Fluorobenzenes; Heart Rate; Hemodynamics; Isoproterenol; Oxygen Consumption; Physical Conditioning, Animal; Propanolamines | 1990 |
Controlled beta-receptor blockade with flestolol: a novel ultrashort-acting beta-blocker.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Drug Interactions; Female; Fluorobenzenes; Heart Rate; Isoproterenol; Kinetics; Liver; Male; Propanolamines; Rabbits; Reserpine | 1987 |
[The effect of beta-receptor blockers on the isoprenaline-induced increase of heart muscle oxygen consumption].
Topics: Adrenergic beta-Antagonists; Animals; Bupranolol; Fluorobenzenes; Isoproterenol; Myocardium; Oxygen Consumption; Propanolamines; Swine | 1985 |
Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonist.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Fluorobenzenes; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Isoproterenol; Male; Propanolamines | 1987 |
Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Female; Fluorobenzenes; Humans; Isoproterenol; Male; Middle Aged; Propanolamines; Wolff-Parkinson-White Syndrome | 1988 |
Tolerance and beta-adrenergic blocking activity of flestolol, a short-acting beta blocker.
Topics: Adult; Analysis of Variance; Blood Pressure; Drug Evaluation; Fluorobenzenes; Heart Rate; Humans; Infusions, Parenteral; Isoproterenol; Male; Propanolamines; Tachycardia | 1986 |